Fear of missing out: Drug availability in the United States vs Canada
There was similar access to important prescription drug therapies in the United States and Canada. Overall, the additional spending in the United States may not have necessarily translated into access to important therapeutic innovations.
Authors
- Joel Lexchin (ORCID: https://orcid.org/0000-0001-5120-8029)
- Katie J. Suda
- Inmaculada Hernandez (ORCID: https://orcid.org/0000-0002-0118-4986)
- Mina Tadrous (ORCID: https://orcid.org/0000-0003-1911-6129)
- Martin Ho (ORCID: https://orcid.org/0000-0001-5160-0776)
- Katherine Callaway Kim (ORCID: https://orcid.org/0000-0002-2924-6165)
- Clara Chen
Institutions
- University of Pittsburgh (US)
- University of Toronto (CA)
- VA Pittsburgh Healthcare System (US)
- University of Montana (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2024-11-29
- DOI
- https://doi.org/10.18553/jmcp.2024.30.12.1349
- Citations
- 2
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 2.26